Welcome to our dedicated page for Scotts Miracle Gr SEC filings (Ticker: SMG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Lawn lovers dissect Scotts Miracle-Gro’s fertilizer formulas; indoor cultivators parse Hawthorne hydroponic margins. Yet the financial story behind every bag of Miracle-Gro often hides inside dense disclosures. If you’ve searched “Scotts Miracle-Gro insider trading Form 4 transactions” or wondered how costs shift in a “Scotts Miracle-Gro quarterly earnings report 10-Q filing,” you know the challenge. Stock Titan solves it by delivering Scotts Miracle-Gro SEC filings explained simply, combining EDGAR speed with contextual AI.
Our platform ingests each submission the moment it posts to the SEC, then provides:
- AI-powered summaries that translate legal language into clear takeaways
- Real-time alerts for Scotts Miracle-Gro Form 4 insider transactions real-time
- Side-by-side comparisons so understanding Scotts Miracle-Gro SEC documents with AI becomes second nature
- Segment drill-downs linking hydroponic sales or fertilizer demand directly to the footnotes that matter
Whether you need Scotts Miracle-Gro earnings report filing analysis before the market opens, a Scotts Miracle-Gro annual report 10-K simplified for long-term forecasting, or a deep dive into Scotts Miracle-Gro proxy statement executive compensation, our coverage is exhaustive. We also flag every Scotts Miracle-Gro executive stock transactions Form 4 and keep you informed with Scotts Miracle-Gro 8-K material events explained. From seasonal fertilizer demand swings to evolving cannabis regulations, the insights investors rely on are only a click away.
The Scotts Miracle-Gro Company major shareholder group led by the Hagedorn family has updated its Schedule 13D to reflect current holdings and new financing and trading arrangements. Hagedorn Partnership, L.P. reports beneficial ownership of 13,217,641 common shares, or 22.8% of the company’s common stock, based on 57,995,369 shares outstanding as reported in the company’s Form 10-K filed on November 25, 2025. Individual reporting persons, including James Hagedorn, report beneficial ownership levels of up to 13,352,309.71 shares, or 23.0% of the common stock.
On September 16, 2025, the partnership, on behalf of Katherine Hagedorn Littlefield, adopted a Rule 10b5-1 trading plan providing for periodic sales of up to an aggregate of 130,000 shares beginning on December 18, 2025, ending when all sale orders are executed or on December 17, 2026, or earlier termination under the plan’s terms. On December 9, 2025, the partnership also entered into a Credit Agreement with Wells Fargo Bank for a revolving line of credit of up to
The Scotts Miracle-Gro Company director reports a routine equity-related transaction. On 12/05/2025, a director of Scotts Miracle-Gro Co. filed a Form 4 detailing the accrual of 121 dividend equivalent rights tied to existing deferred stock unit (DSU) or restricted stock unit (RSU) grants. These dividend equivalent rights become exercisable proportionately with the DSUs or RSUs they relate to, and each right is the economic equivalent of one common share of the issuer.
Following this transaction, the reporting person held 783 derivative securities directly. The filing reflects standard equity compensation mechanics rather than a cash transaction in the company’s stock.
The Scotts Miracle-Gro Company executive reports derivative equity awards. EVP, CFO & CAO Mark J. Scheiwer filed a Form 4 showing two transactions dated 12/05/2025. He acquired 50 dividend equivalent rights, each economically equal to one common share of Scotts Miracle-Gro, bringing his total beneficially owned derivative position in this award type to 363 units. He also acquired 14.07 shares of phantom stock, increasing his phantom stock balance to 1,187.36 units. Dividend equivalent rights accrue on DSU or RSU grants and become exercisable proportionately with the related awards, while each share of phantom stock represents the right to receive one common share or its cash value, generally payable in cash after employment ends.
Scotts Miracle-Gro Company director files Form 4 for derivative award. A company director reported acquiring 18 dividend equivalent rights on December 5, 2025, tied to existing deferred stock unit (DSU) or restricted stock unit (RSU) grants. These rights become exercisable in step with the related DSUs or RSUs and each right is the economic equivalent of one common share of Scotts Miracle-Gro. Following this transaction, the director beneficially owned 33 derivative securities in direct ownership form.
Scotts Miracle-Gro director David C. Evans reported a routine equity-related change in ownership. On 12/05/2025, he acquired 121 dividend equivalent rights linked to deferred stock units (DSUs) or restricted stock units (RSUs). Each dividend equivalent right is described as the economic equivalent of one common share of Scotts Miracle-Gro. Following this transaction, Evans beneficially owned 783 derivative securities, held directly. These rights accrue on prior DSU or RSU grants and become exercisable proportionately with the underlying units.
Scotts Miracle-Gro director reports derivative equity accruals. A Form 4 filing shows director Nick Miaritis reported a transaction dated 12/05/2025 involving dividend equivalent rights linked to deferred stock units (DSUs) or restricted stock units (RSUs) of Scotts Miracle-Gro Co. (SMG).
The filing reports the acquisition of 37 dividend equivalent rights, which are derivative securities that become exercisable proportionately with the related DSUs or RSUs. Each dividend equivalent right is described as the economic equivalent of one common share of Scotts Miracle-Gro. Following this transaction, Miaritis is shown as beneficially owning 130 derivative securities of this type, held directly.
The Scotts Miracle-Gro Company director Mark D. Kingdon reported a small equity-related award. On 12/05/2025, a Form 4 filing shows the acquisition of 106 dividend equivalent rights tied to existing deferred stock unit (DSU) or restricted stock unit (RSU) grants. Each dividend equivalent right is described as the economic equivalent of one common share of Scotts Miracle-Gro.
Following this transaction, Kingdon beneficially owned 612 derivative securities in total, held in direct ownership form. The filing clarifies that these dividend equivalent rights become exercisable proportionately with the underlying DSUs or RSUs, aligning their value with the company’s common shares over time.
The Scotts Miracle-Gro Company director reports additional derivative equity units. A reporting person serving as a director of The Scotts Miracle-Gro Company (SMG) filed a Form 4 disclosing a derivative equity transaction dated 12/05/2025. The filing shows an acquisition of 159 dividend equivalent rights, which are linked to previously granted deferred stock units (DSUs) or restricted stock units (RSUs).
According to the disclosure, each dividend equivalent right is the economic equivalent of one common share of Scotts Miracle-Gro and becomes exercisable proportionately with the related DSUs or RSUs. Following this transaction, the reporting person beneficially owns 948 derivative securities tied to common shares on a direct basis. This reflects routine equity-based compensation activity rather than a cash transaction.
The Scotts Miracle-Gro Company director reports routine equity-based compensation activity. A company director filed a Form 4 disclosing the acquisition of 42 dividend equivalent rights tied to existing deferred stock units (DSUs) or restricted stock units (RSUs) on 12/05/2025. After this transaction, the reporting person holds 150 derivative securities directly. The filing explains that each dividend equivalent right is economically equal to one common share of Scotts Miracle-Gro and vests proportionately with the related DSUs or RSUs, reflecting ongoing alignment of director compensation with shareholder interests rather than a cash transaction.
Scotts Miracle-Gro director reports dividend-equivalent award
A director of Scotts Miracle-Gro Co. reported a routine equity-related transaction involving derivative securities. On 12/05/2025, the reporting person acquired 187 dividend equivalent rights, recorded as an "A" (acquired) transaction. These rights are tied to existing deferred stock unit (DSU) or restricted stock unit (RSU) grants and become exercisable proportionately with the underlying DSUs or RSUs.
Each dividend equivalent right is described as the economic equivalent of one common share of Scotts Miracle-Gro. Following this transaction, the reporting person beneficially owned 1,210 derivative securities on a direct basis, reflecting ongoing participation in the company’s equity-based compensation programs rather than a change in control or role.
FAQ
What is the current stock price of Scotts Miracle Gr (SMG)?
What is the market cap of Scotts Miracle Gr (SMG)?
